Results
fatigue
Table Participant characteristics (n = 78).Data are shown as the means ± standard error or frequency counts (%). The numbers of participants for whom SB, light-intensity PA (LPA), and MVPA could not be assessed during each study period are presented in Supplemental Table Time-related changes in the meantime spent in sedentary behavior, light-intensity physical activity, and moderate- to vigorous-intensity physical activity.The number of participants for whom physical activity could not be assessed during each study period is shown in Supplementary Table Table Effects of LTP ingestion and physical activity intervention on anthropometry, blood pressure, and dietary habits (n = 78).Data are mean ± standard error for baseline and post-intervention and mean (95% confidence interval) for changes at 8 weeks. The results of the simple correlations between fatigue and mood status before and after the intervention are shown in Supplemental Table Table Effects of LTP ingestion and physical activity intervention on fatigue and mood status (n = 78).Data are presented as mean ± standard error for baseline and post-intervention and mean (95% confidence interval) for changes at 8 weeks. Although we confirmed that the participants were not taking angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers before the study began, two participants in the placebo and LTP + PA groups were taking angiotensin II receptor blockers when their prescription records were checked after the study was completed. In addition, one participant in the LTP + PA group did not participate in any supervised session other than the first session, and no PA data were obtained. The results, excluding these three participants (taking angiotensin II receptor blockers, n = 2; rarely participated in supervised sessions, n = 1), are shown in Supplemental Table Figure The simple correlations between the changes in MVPA time and the changes in TMD (